Document:

EX-10.2

 Exhibit 10.2 

AMENDMENT TO TERM LOAN CREDIT AGREEMENT 

This AMENDMENT to the Term Loan Credit Agreement, dated as of February 1, 2018 (this “Amendment”), is made and entered
into by and among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim,
Jerusalem, ISRAEL (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 1090 Horsham Road, North Wales, Pennsylvania, United States of America
(“Teva USA” or the “US Borrower”), TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V., a besloten vennootschap incorporated under the laws of the Netherlands, with its official seat (statutaire zetel) in Amsterdam,
the Netherlands and the registered address of which is Piet Heinkade 107, 1019GM Amsterdam, registered with the Dutch trade register under number 855546876 (the “Dutch Borrower”), TEVA FINANCE SERVICES B.V., a Curaçao company
registered under no. 105859 (0), the registered address of which is at Schout Bij Nacht Doormanweg 40, Curaçao (“Teva Curaçao I”), TEVA FINANCE SERVICES II B.V., a Curaçao company registered under no. 119570
(0), the registered address of which is at Schout Bij Nacht Doormanweg 40, Curaçao (“Teva Curaçao II”), TEVA CAPITAL SERVICES SWITZERLAND GMBH, a company organized under the laws of Switzerland, registered under number
CHE-113.868.008 (the “Swiss Borrower” and, together with Teva USA, the Dutch Borrower, Teva Curaçao I and Teva Curaçao II, the “Borrowers”),
CITIBANK, N.A., (the “Administrative Agent”), and the Required Lenders (as defined in the Credit Agreement defined below) party hereto. 

W I T N E S S E T H. 

Reference is made to the Term Loan Credit Agreement dated as of November 16, 2015 (as amended from time to time, the “Credit
Agreement”), between, amongst others, the Parent, the Borrowers, the Lenders named therein and the Administrative Agent. 

WHEREAS, the Loan Parties (as defined in the Credit Agreement), the Administrative Agent and the Lenders party hereto have agreed to amend
certain provisions of the Credit Agreement as provided for herein; 
 NOW, THEREFORE, in consideration of the mutual conditions and
agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

ARTICLE I 
 Defined Terms

 Section 1.1 Defined Terms. Each capitalized term used in this Amendment, unless otherwise defined herein, shall have the
meaning ascribed to such term in the Credit Agreement. 

  
 1 

 ARTICLE II 

Amendments 

Section 2.1 Amendments. Subject to the occurrence of the Amendment Effective Date: 

(a) Section 1.01 of the Credit Agreement is hereby amended by inserting in appropriate alphabetical order the following new
definitions: 
 ““Existing Term Loans” means (a) the Senior Unsecured Japanese Yen Term Loan Agreement among et
al. the Parent, Teva Holdings K.K. and Sumitomo Mitsui Banking Corporation, as administrative agent, dated March 22, 2017 and/or (b) the Senior Unsecured Japanese Yen Term Loan Agreement among et al. the Parent, Teva Holdings K.K. and
Mizuho Bank, Ltd., as administrative agent, dated December 17, 2013 and/or (c) the Senior Unsecured Fixed Rate Japanese Yen Term Loan Credit Agreement among et al. the Parent, Teva Holdings K.K. (f/k/a Teva Holdings GK) and Sumitomo Mitsui
Banking Corporation, as administrative agent, dated March 28, 2012 (in each case as the same may be amended or restated from time to time).” 

(b) Section 2.08(a) of the Credit Agreement is hereby amended by adding the following sentence to the end thereof: 

“Notwithstanding the foregoing or anything contained herein to the contrary, if Parent or any of its Subsidiaries use net cash proceeds
from a disposition or an incurrence of third party Indebtedness for borrowed money in the form of loans and/or notes (“Pari Passu Prepayment Net Cash Proceeds”) to prepay any amount under the Existing Term Loans, the Borrowers shall
prepay the Loans such that the aggregate prepayment of the Loans shall be no less than such Loans’ ratable percentage of all of the Loans and Existing Term Loans outstanding on the date of such prepayment with respect to the amount of such Pari
Passu Prepayment Net Cash Proceeds and, with respect to a prepayment in accordance with this sentence, the integral multiple amounts set forth in clause (b) below shall be inapplicable (it being understood that no Borrower shall be required to
make a prepayment as a result of the receipt of net cash proceeds from a disposition or an incurrence of Indebtedness). 
 To determine any
principal amount outstanding or amount of prepayment for purposes of the immediately preceding sentence, (i) all currency conversions shall be determined using the Dollar Equivalent on the date that is seven Business Days preceding the
prepayment date and (ii) the pro rata prepayment requirement shall be satisfied if the aggregate prepayment of Loans shall be no less than such Loans’ ratable percentage of all of the Loans and Existing Term Loans outstanding on such date
of determination. 
 “Dollar Equivalent” means the amount converted into Dollars using the 12:00 p.m. New York City
quoted spot rate appearing at http://www.oanda.com/currency/converter for Yen on such day or, if such day is not a Business Day, on the immediately preceding Business Day; provided that, to the extent that a spot rate is not ascertainable pursuant
to the foregoing provisions of this definition, the “Dollar Equivalent” shall be the rate at which Citibank, N.A. offers, in accordance with normal banking industry practice, to exchange Yen in New York City prior to 12:00 p.m., New York
City time, on such date.” 
 (c) Section 6.01(xiii) of the Credit Agreement is hereby deleted and replaced in its
entirety with the following: 
 “(xiii) the Parent may pay cash dividends (or dividends paid in the form of common equity of the Parent)
to its shareholders, to the extent lawful; provided that the Parent shall not pay any cash dividends on its common equity unless the Leverage Ratio, calculated as of the last day of the most recently ended Test Period in accordance with
Section 6.04 

  
 2 

 
and on a pro forma basis giving effect to such cash dividend and any other cash dividends made since the end of the last Test Period, does not exceed 4.75x and so long as no Event of Default has
occurred and is continuing (or would result therefrom) (it being understood and agreed that this proviso shall not restrict any dividends to the holders of the Parent’s preferred equity, including the Parent’s mandatory convertible
preferred shares, or dividends paid in the form of common equity of the Parent),” 
 (d) Section 6.04 of the Credit
Agreement is hereby amended by deleting the grid contained therein and replacing it with the grid below: 
  

					
	 	  	 Column 1
	  	 Column 2

	 	  	 Four-quarter Test
Period
 ending with the quarters

below
	  	 
	(a) Leverage Ratio	  	Q1 2018	  	No greater than 5.50x
	  	Q2 2018	  	No greater than 5.75x
	  	Q3 2018	  	No greater than 5.90x
	  	Q4 2018	  	No greater than 5.90x
	  	Q1 2019	  	No greater than 5.75x
	  	Q2 2019	  	No greater than 5.50x
	  	Q3 2019	  	No greater than 5.25x
	  	Q4 2019	  	No greater than 5.00x
	  	Q1 2020	  	No greater than 4.75x
	  	Q2 2020	  	No greater than 4.75x
	  	Q3 2020 and thereafter	  	No greater than 4.50x
		
	(b) Interest Cover Ratio	  	The Interest Cover Ratio for any Test Period shall be not less than 3.50:1.

 ARTICLE III 

Representations and Warranties 

Section 3.1 Representations and Warranties to the Amendment Effective Date. Each Loan Party hereby represents and warrants as of
the Amendment Effective Date as follows: 
 (a) all of the representations and warranties set forth in the Credit Agreement
are true and correct on and as of such date, as if made on such date, except to the extent that such representations and warranties specifically relate to an earlier date, in which case such representations and warranties shall have been true and
correct on and as of such earlier date (it being understood that references therein to the Credit Agreement shall be deemed to refer to the Credit Agreement as amended by this Amendment and after giving effect to the amendments set forth herein);

 (b) the execution, delivery and performance by each Loan Party of this Amendment have been duly authorized by all
necessary corporate or other organizational action, as applicable, of such Loan Party; 
 (c) this Amendment has been duly
executed and delivered by such Loan Party; and 

  
 3 

 (d) no Default or Event of Default has occurred, is continuing or would exist
after giving effect to this Amendment. 
 ARTICLE IV 

Effectiveness 

Section 4.1 Effective Date. This Amendment shall become effective on the date (the “Amendment Effective Date”) on
which: 
 (a) the Administrative Agent shall have received counterparts to this Amendment duly executed and delivered by
facsimile transmission or electronic mail (in “.pdf” or similar format) by each Loan Party, the Administrative Agent and the Required Lenders; and 

(b) the aggregate commitments under the Senior Unsecured Revolving Credit Agreement, dated as of November 16, 2015, among
the Loan Parties, the Administrative Agent and the lenders thereto, as amended, have been reduced to no more than US$3,000,000,000. 

Section 4.2 Fees. 

(a) The Loan Parties shall pay or cause to be paid to the Administrative Agent, for the account of each Lender that delivers an
executed counterpart to this Amendment on or before January 31, 2018 (each, a “Consenting Lender”) an amendment fee equal to 0.10% of the sum of such Consenting Lender’s outstanding Loans under the Credit Agreement (the
“Consenting Lender Loans”) as of the Amendment Effective Date, which fee shall be earned on the Amendment Effective Date and due and payable within two Business Days of the Amendment Effective Date; provided that upon any assignment
or transfer of any Consenting Lender Loans; the assignee or transferee shall become the Consenting Lender with respect to such Consenting Lender Loans. 

(b) The Loan Parties shall pay or cause to be paid to the Administrative Agent, for the account of the Consenting Lenders, an
additional amendment fee equal to 0.10% of the sum of such Consenting Lender’s Consenting Lender Loans under the Credit Agreement as of March 31, 2018 (or, at the election of the Borrower, on such earlier date the Borrower may elect in its
sole discretion to pay such fee), which fee shall be earned on March 31, 2018 and due and payable on April 2, 2018 (or, at the election of the Borrower, on such earlier date the Borrower may elect in its sole discretion). 

(c) The Loan Parties shall pay or cause to be paid to the Administrative Agent, for the account of the Consenting Lenders, an
additional incentive fee to each Consenting Lender that delivers an executed counterpart to this Amendment on or before January 26, 2018 (subject to the proviso at the end of Section 4.2(a)) equal to (i) 0.05% of the sum of such Consenting
Lender’s Consenting Lender Loans as of the Amendment Effective Date, which fee shall be earned on the Amendment Effective Date and due and payable within two Business Days of the Amendment Effective Date and (ii) 0.05% of the sum of such
Consenting Lender’s Consenting Lender Loans as of March 31, 2018 (or, at the election of the Borrower, on such earlier date the Borrower may elect in its sole discretion to pay such fee), which fee shall be earned on March 31, 2018
and due and payable on April 2, 2018 (or, at the election of the Borrower, on such earlier date the Borrower may elect in its sole discretion). 

  
 4 

 (d) For the avoidance of doubt, all fees under this Section 4.2 shall be due
and payable to the applicable Consenting Lender with respect to their Consenting Lender Loans (determined in accordance with this Section 4.2) taking into account any assignments or transfers of such Consenting Lender Loans after the signature
by a Consenting Lender as set forth in Section 4.2(a). 
 Section 4.3 Expenses. The Loan Parties shall pay all reasonable
and documented out-of-pocket expenses incurred by the Administrative Agent and the Lenders, including the reasonable fees, charges and disbursements of counsel for the
Administrative Agent and the Lenders, in connection with this Amendment. 
 Section 4.4 Notification. The Administrative Agent
shall notify the Loan Parties and the Lenders of the Amendment Effective Date and such notice shall be conclusive and binding. 
 ARTICLE V

 Miscellaneous 

Section 5.1 Effect of Amendment. Except as modified pursuant hereto, no other changes or modifications to the Credit Agreement or
Loan Documents are intended or implied and in all other respects the Credit Agreement and Loan Documents are hereby specifically ratified, restated and confirmed by all parties hereto as of the effective date hereof. To the extent of conflict
between the terms of this Amendment and the Loan Documents, the terms of this Amendment shall control. The Credit Agreement and this Amendment shall be read and construed as one agreement. 

Section 5.2 Further Assurances. The parties hereto shall execute and deliver such additional documents and take such additional
action as may be reasonably necessary or desirable to effectuate the provisions and purposes of this Amendment. 
 Section 5.3
Binding Effect. This Amendment shall be binding upon and inure to the benefit of each of the parties hereto and their respective successors and assigns. 

Section 5.4 Severability. Any provisions of this Amendment that is prohibited or unenforceable in any jurisdiction shall, as to
such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction. 
 Section 5.5 Reference to the Effect on the Loan Documents. Upon the
effectiveness of this Amendment, (a) each reference in the Credit Agreement to this “Agreement,” “hereunder,” “hereof,” “herein” or words of similar import and (b) each reference in any other Loan
Document to “the Credit Agreement”, shall mean and be a reference to the Credit Agreement as amended by this Amendment. 

Section 5.6 Headings. The headings listed herein are for convenience only and do not constitute matters to be construed in
interpreting this Amendment. 
 Section 5.7 Counterparts; Electronic Signatures. This Amendment may be executed by one or more
parties to this Amendment on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Amendment by facsimile
transmission or electronic mail (in “.pdf” or similar format) shall be effective as delivery of a manually executed counterpart hereof. 

  
 5 

 Section 5.8 Governing Law; Jurisdiction; Consent to Service of Process. 

(a) This Amendment and the rights and obligations of the parties under this Amendment shall be governed by, and construed and
interpreted in accordance with, the law of the State of New York without regard to conflict of law principles that would result in the application of any law other than the law of the State of New York. 

(b) Each party hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive
jurisdiction of the Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate court from any thereof, in any action or proceeding arising out of
or relating to this Amendment, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in
such New York State or, to the extent permitted by law, in such federal court. To the extent that any Loan Party has or hereafter may acquire any immunity from jurisdiction of any court or from any legal process (whether through service or notice,
attachment prior to judgment, attachment in aid of execution, execution or otherwise) with respect to itself or its property, such Loan Party hereby irrevocably waives such immunity in respect of its obligations under this Amendment. Each of the
parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Amendment shall affect any
right that the Administrative Agent or any Lender may otherwise have to bring any action or proceeding relating to this Amendment against any Borrower or the Guarantor or any of their respective properties in the courts of any jurisdiction to
enforce a judgment obtained in accordance with this Section. 
 (c) Each Loan Party hereby irrevocably and unconditionally
waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Amendment in any court referred to in
paragraph (b) of this Section. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court. 

(d) Each party to this Amendment irrevocably consents to service of process in the manner provided for notices in
Section 11.01 of the Credit Agreement. In addition, each Loan Party (other than Teva USA) hereby irrevocably designates, appoints and empowers Teva USA (the “Process Agent”), in the case of any suit, action or proceeding
brought in the United States as its designee, appointee and agent to receive, accept and acknowledge for and on its behalf, and in respect of its property, service of any kind and all legal process, summons, notices and documents that may be served
in any action or proceeding arising out of or in connection with this Amendment or any other Loan Document. By executing this Amendment, Teva USA hereby irrevocably accepts such designation, appointment and agency, which shall remain in full force
and effect until such time as Teva USA ceases to be a Borrower under the Credit Agreement (at which time each Loan Party shall designate a replacement Process Agent satisfactory to the Administrative Agent (and deliver the appropriate documentation
in respect thereof as reasonably requested by the Administrative Agent)). Such service may be made by mailing (by registered or certified mail, postage prepaid) or delivering a copy of such process to such Person in care of the Process Agent at the
Process Agent’s above address, and such Person hereby irrevocably authorizes and directs the Process Agent to accept such service on its behalf. As an alternative method of service, each Loan Party irrevocably consents to the service of any and
all process in any such action or proceeding by the mailing (by registered or certified mail, postage prepaid) of copies of such process to the Process Agent or such Person at its address specified in Section 11.01 of the Credit

  
 6 

 
Agreement. Nothing in this Amendment will affect the right of any party to this Amendment to serve process in any other manner permitted by law. 

[Remainder of this page intentionally left blank] 
  

  
 7 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered by
their respective duly authorized officers as of the date first above written. 
  

			
	 TEVA PHARMACEUTICAL INDUSTRIES

LIMITED

		
	By:	 	 /s/ Eran Ezra

		 	Name: Eran Ezra
		 	Title: Senior Vice President, Head of Global Treasury, Risk Management and Insurance
		
	By:	 	 /s/ Michael McClellan

		 	Name: Michael McClellan
		 	Title: Executive Vice President, Chief Financial Officer
	
	TEVA PHARMACEUTICALS USA, INC.
		
	By:	 	 /s/ Deborah A. Griffin

		 	Name: Deborah A. Griffin
		 	Title: Senior Vice President, Finance and Chief Financial Officer
		
	By:	 	 /s/ Gudjon Gustafsson

		 	Name: Gudjon Gustafsson
		 	Title: Head of Treasury
	
	 TEVA PHARMACEUTICAL FINANCE

NETHERLANDS III B.V.

		
	By:	 	 /s/ Richard Daniell

		 	Name: Richard Daniell
		 	Title: Managing Director
		
	By:	 	 /s/ David Vrhovec

		 	Name: David Vrhovec
		 	 Title: Managing Director

	
	TEVA FINANCE SERVICES B.V.
		
	By:	 	 /s/ Gudjon Gustafsson

		 	Name: Gudjon Gustafsson
		 	Title: Managing Director
		
	By:	 	 /s/ David Koch

		 	Name: David Koch
		 	 Title: Managing Director

 [Signature Page to Amendment to Term Loan Credit Agreement] 

 
			
	TEVA FINANCE SERVICES II B.V.
		
	By:	 	 /s/ Gudjon Gustafsson

		 	Name: Gudjon Gustafsson
		 	Title: Managing Director
		
	By:	 	 /s/ David Koch

		 	Name: David Koch
		 	Title: Managing Director
	
	 TEVA CAPITAL SERVICES SWITZERLAND

GMBH

		
	By:	 	 /s/ Gudjon Gustafsson

		 	Name: Gudjon Gustafsson
		 	Title: General Manager
		
	By:	 	 /s/ David Koch

		 	Name: David Koch
		 	Title: President of the Managing Officers

 [Signature Page to Amendment to Term Loan Credit Agreement] 

 
			
	CITIBANK N.A., as Administrative Agent
		
	By:	 	 /s/ Rizwan Shaikh

		 	Name: Rizwan Shaikh
		 	Title: Managing Director

 [Signature Page to Amendment to Term Loan Credit Agreement] 

 [Signature pages of Lenders omitted and on file with the registrant] 

[Signature Page to Amendment to Term Loan Credit Agreement]EX-10.3

 Exhibit 10.3 

AMENDMENT TO SENIOR UNSECURED FIXED RATE JAPANESE YEN TERM LOAN 

CREDIT AGREEMENT 

This AMENDMENT to the Senior Unsecured Fixed Rate Japanese Yen Term Loan Credit Agreement, dated as of February 1, 2018 is made and
entered into by and among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim,
Jerusalem, ISRAEL (the “Company”, “Guarantor” or “Parent”), TEVA HOLDINGS K.K. (f/k/a Teva Holdings GK), a Kabushiki Kaisha organized under the laws of Japan registered under no 0104-03-008857, the registered address of which is at 1-5, Toranomon 5-chome, Minato-ku, Tokyo, Japan, and a Subsidiary of the Company (“Teva Japan” or the “Borrower”), the Lenders party hereto and SUMITOMO MITSUI BANKING CORPORATION. (the
“Administrative Agent”). 
 W I T N E S S E T H: 

Reference is made to the Senior Unsecured Fixed Rate Japanese Yen Term Loan Credit Agreement, dated as of March 28, 2012 (as amended from
time to time, the “Credit Agreement”), between, amongst others, the Parent, the Borrower, the Lenders named therein and the Administrative Agent. 

WHEREAS, the Loan Parties (as defined in the Credit Agreement), the Administrative Agent and the Lenders party hereto have agreed to amend
certain provisions of the Credit Agreement as provided for herein; 
 NOW, THEREFORE, in consideration of the mutual conditions and
agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

ARTICLE I 
 Defined Terms

 Section 1.1 Defined Terms. Terms defined in the Credit Agreement and used herein shall have the meanings given to them in
the Credit Agreement unless otherwise defined herein. 
 ARTICLE II 

Amendments 

Section 2.1 Amendments. Subject to the occurrence of the Amendment Effective Date: 

(a) Section 1.01 of the Credit Agreement is hereby amended by inserting in appropriate alphabetical order the following new
definitions: 
 ““Existing Term Loans” means (a) the Senior Unsecured Japanese Yen Term Loan Agreement among et
al. the Parent, Teva Japan and Sumitomo Mitsui Banking Corporation, as administrative agent, dated March 22, 2017 and/or (b) the Senior Unsecured Japanese Yen Term Loan Agreement among et al. the Parent, Teva Japan and Mizuho Bank, Ltd.,
as administrative agent, dated December 17, 2013 and/or (c) the Term Loan Credit 

 
Agreement, dated November 16, 2015, among et al. the Parent, Teva Pharmaceuticals USA, Inc., the other Subsidiaries of the Parent party thereto as borrowers and Citibank, N.A.
(“Citibank”), as administrative agent (in each case as the same may be amended or restated from time to time).” 

(b) Section 2.08(a) of the Credit Agreement is hereby amended by adding the following sentence to the end thereof: 

“Notwithstanding the foregoing or anything contained herein to the contrary, if the Parent or any of its Subsidiaries use net cash
proceeds from a disposition or an incurrence of third party Indebtedness for borrowed money in the form of loans and/or notes (“Pari Passu Prepayment Net Cash Proceeds”) to prepay any amount under the Existing Term Loans, the
Borrowers shall prepay the Loans such that the aggregate prepayment of the Loans shall be no less than such Loans’ ratable percentage of all of the Loans and Existing Term Loans outstanding on the date of such prepayment with respect to the
amount of such Pari Passu Prepayment Net Cash Proceeds and, with respect to a prepayment in accordance with this sentence, the integral multiple amounts set forth in paragraph (b) below shall be inapplicable (it being understood that no
Borrower shall be required to make a prepayment as a result of the receipt of net cash proceeds from a disposition or an incurrence of Indebtedness). 

To determine any principal amount outstanding or amount of prepayment for purposes of the immediately preceding sentence, (i) all currency
conversions shall be determined using the Yen Equivalent on the date that is seven Business Days preceding the prepayment date and (ii) the pro rata prepayment requirement shall be satisfied if the aggregate prepayment of Loans (across all
Tranches) shall be no less than such Loans’ ratable percentage of all of the Loans and Existing Term Loans outstanding on such date of determination. 

“Yen Equivalent” means the amount converted into Yen using the 12:00 p.m. New York City quoted spot rate appearing at
http://www.oanda.com/currency/converter for Dollars on such day or, if such day is not a Business Day, on the immediately preceding Business Day; provided that, to the extent that a spot rate is not ascertainable pursuant to the foregoing provisions
of this definition, the “Yen Equivalent” shall be the rate at which Citibank offers, in accordance with normal banking industry practice, to exchange Dollars in New York City prior to 12:00 p.m., New York City time, on such date.”

 (c) Section 6.01(xiii) of the Credit Agreement is hereby deleted and replaced in its entirety with the following: 

“(xiii) the Parent may pay cash dividends (or dividends paid in the form of common equity of the Parent) to its shareholders, to the
extent lawful; provided that the Parent shall not pay any cash dividends on its common equity unless the Leverage Ratio, calculated as of the last day of the most recently ended Test Period in accordance with Section 6.04 and on a pro forma
basis giving effect to such cash dividend and any other cash dividends made since the end of the last Test Period, does not exceed 4.75x and so long as no Event of Default has occurred and is continuing (or would result therefrom) (it being
understood and agreed that this proviso shall not restrict any dividends to the holders of the Parent’s preferred equity, including the Parent’s mandatory convertible preferred shares, or dividends paid in the form of common equity of the
Parent),” 

 (d) Section 6.04 of the Credit Agreement is hereby amended by deleting the grid
contained therein and replacing it with the grid below: 
  

					
	 	  	 Column 1
	  	 Column 2

	 	  	 Four-quarter Test
Period
 ending with the quarters

below
	  	 
	(a) Leverage Ratio	  	Q1 2018	  	No greater than 5.50x
	  	Q2 2018	  	No greater than 5.75x
	  	Q3 2018	  	No greater than 5.90x
	  	Q4 2018	  	No greater than 5.90x
	  	Q1 2019 and thereafter	  	No greater than 5.75x
		
	(b) Interest Cover Ratio	  	The Interest Cover Ratio for any Test Period shall be not less than 3.50:1.

 (e) Annex I of the Credit Agreement is hereby amended by amending and restating the second
paragraph (following the Rate Table) as follows: 
 “If the relevant Rating assigned by Moody’s or S&P shall be changed (other
than as a result of a change in the rating system of Moody’s or S&P), such change shall be effective with respect to the Applicable Margin from the first day of the next Interest Period at least seven Business Days following the effective
date of such change in Rating. If the rating system of Moody’s or S&P shall change or if either such rating agency shall cease to be in the business of rating corporate debt obligations, the Parent and the Lenders shall negotiate in good
faith to amend this definition to reflect such changed rating system (including, in such case, an amendment to replace Moody’s or S&P, as applicable, with another rating agency) or the unavailability of ratings from such rating agency, and,
pending the effectiveness of any such amendment, the Applicable Margin shall be determined by reference to the rating most recently in effect prior to such change or cessation.” 

ARTICLE III 
 Representations
and Warranties 
 Section 3.1 Representations and Warranties to the Amendment Effective Date. Each Loan Party hereby
represents and warrants as of the Amendment Effective Date as follows: 
 (a) all of the representations and warranties set
forth in the Credit Agreement are true and correct on and as of such date, as if made on such date, except to the extent that such representations and warranties specifically relate to an earlier date, in which case such representations and
warranties shall have been true and correct on and as of such earlier date (it being understood that references therein to the Credit Agreement shall be deemed to refer to the Credit Agreement as amended by this Amendment and after giving effect to
the amendments set forth herein); 
 (b) the execution, delivery and performance by each Loan Party of this Amendment have
been duly authorized by all necessary corporate or other organizational action, as applicable, of such Loan Party; 
 (c)
this Amendment has been duly executed and delivered by such Loan Party; and 
 (d) no Default or Event of Default has
occurred, is continuing or would exist after giving effect to this Amendment. 

 ARTICLE IV 

Effectiveness 

Section 4.1 Effective Date. This Amendment shall become effective on the date (the “Amendment Effective Date”) on
which the Administrative Agent shall have received counterparts to this Amendment duly executed and delivered by facsimile transmission or electronic mail (in “.pdf” or similar format) by each Loan Party, the Administrative Agent and the
Required Lenders. 
 Section 4.2 Fees. 

(a) The Loan Parties shall pay or cause to be paid to the Administrative Agent, for the account of each Lender that delivers an
executed counterpart to this Amendment on or before 11.59pm (Tokyo time) on January 31, 2018 (each, a “Consenting Lender”) an amendment fee equal to 0.10% of the sum of such Consenting Lender’s outstanding Loans under the
Credit Agreement (the “Consenting Lender Loans”) as of the Amendment Effective Date, which fee shall be earned on the Amendment Effective Date and due and payable within two Business Days of the Amendment Effective Date; provided
that upon any assignment or transfer of any Consenting Lender Loans; the assignee or transferee shall become the Consenting Lender with respect to such Consenting Lender Loans. 

(b) The Loan Parties shall pay or cause to be paid to the Administrative Agent, for the account of the Consenting Lenders, an
additional amendment fee equal to 0.10% of the sum of such Consenting Lender’s outstanding Consenting Lender Loans as of March 31, 2018 (or, at the election of the Borrower, on such earlier date the Borrower may elect in its sole
discretion to pay such fee), which fee shall be earned on March 31, 2018 and due and payable on April 2, 2018 (or, at the election of the Borrower, on such earlier date the Borrower may elect in its sole discretion). 

(c) The Loan Parties shall pay or cause to be paid to the Administrative Agent, for the account of the Consenting Lenders, an
additional incentive fee to each Consenting Lender that delivers an executed counterpart to this Amendment on or before 11.59pm (Tokyo time) on January 26, 2018 (subject to the proviso at the end of Section 4.2(a)) equal to (i) 0.05% of the sum
of such Consenting Lender’s Consenting Lender Loans as of the Amendment Effective Date, which fee shall be earned on the Amendment Effective Date and due and payable within two Business Days of the Amendment Effective Date and (ii) 0.05% of the
sum of such Consenting Lender’s Consenting Lender Loans as of March 31, 2018 (or, at the election of the Borrower, on such earlier date the Borrower may elect in its sole discretion to pay such fee), which fee shall be earned on
March 31, 2018 and due and payable on April 2, 2018 (or, at the election of the Borrower, on such earlier date the Borrower may elect in its sole discretion). 

(d) For the avoidance of doubt, all fees under this Section 4.2 shall be due and payable to the applicable Consenting
Lender with respect to their Consenting Lender Loans (determined in accordance with this Section 4.2) taking into account any assignments or transfers of such Consenting Lender Loans after the signature by a Consenting Lender as set forth in
Section 4.2(a).. 

 Section 4.3 Expenses. The Loan Parties shall pay all
out-of-pocket expenses incurred by the Administrative Agent and the Lenders, including the reasonable fees, charges and disbursements of counsel for the Administrative
Agent and the Lenders, in connection with this Amendment. 
 Section 4.4 Notification. The Administrative Agent shall notify the
Loan Parties and the Lenders of the Amendment Effective Date and such notice shall be conclusive and binding. 
 ARTICLE V 

Miscellaneous 

Section 5.1 Effect of Amendment. Except as modified pursuant hereto, no other changes or modifications to the Credit Agreement or
Loan Documents are intended or implied and in all other respects the Credit Agreement and Loan Documents are hereby specifically ratified, restated and confirmed by all parties hereto as of the effective date hereof. To the extent of conflict
between the terms of this Amendment and the Loan Documents, the terms of this Amendment shall control. The Credit Agreement and this Amendment shall be read and construed as one agreement. 

Section 5.2 Further Assurances. The parties hereto shall execute and deliver such additional documents and take such additional
action as may be reasonably necessary or desirable to effectuate the provisions and purposes of this Amendment. 
 Section 5.3
Binding Effect. This Amendment shall be binding upon and inure to the benefit of each of the parties hereto and their respective successors and assigns. 

Section 5.4 Severability. Any provisions of this Amendment that is prohibited or unenforceable in any jurisdiction shall, as to
such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction.  
 Section 5.5 Reference to the Effect on the Loan Documents.
Upon the effectiveness of this Amendment, (a) each reference in the Credit Agreement to this “Agreement,” “hereunder,” “hereof,” “herein” or words of similar import and (b) each reference in any
other Loan Document to “the Credit Agreement”, shall mean and be a reference to the Credit Agreement as amended by this Amendment. 

Section 5.6 Headings. The headings listed herein are for convenience only and do not constitute matters to be construed in interpreting
this Amendment. 
 Section 5.7 Counterparts; Electronic Signatures. This Amendment may be executed by one or more parties to
this Amendment on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Amendment by facsimile transmission or
electronic mail (in “.pdf” or similar format) shall be effective as delivery of a manually executed counterpart hereof.  

Section 5.8 Governing Law. This Amendment and any non-contractual obligations arising out
of or in connection with it shall be construed in accordance with and governed by Japanese law (without regard to conflicts of laws principles). 

Section 5.9 Jurisdiction; Consent to Service of Process. Section 11.10(b), (c) and (d) of the Credit Agreement are
incorporated herein mutatis mutandis. 

 [Remainder of this page intentionally left blank] 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered by
their respective duly authorized officers as of the date first above written. 
  

			
	TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		
	By:	 	 /s/ Eran Ezra

		 	Name: Eran Ezra
		 	Title: Senior Vice President, Head of Global Treasury, Risk Management and Insurance
		
	By:	 	 /s/ Michael McClellan

		 	Name: Michael McClellan
		 	Title: Executive Vice President, Chief Financial Officer
	
	TEVA HOLDINGS K.K.
		
	By:	 	 /s/ TEVA HOLDINGS K.K. (Company Seal)

		 	Name: 
		 	Title: 

 [Signature Page to Amendment to JPY 2012 Credit Agreement] 

 
			
	SUMITOMO MITSUI BANKING CORPORATION, as Administrative Agent
		
	By:	 	 /s/ Konstantinos Karbalis

		 	Name: Konstantinos Karbalis
		 	Title: Senior Executive Director
		
	By:	 	 /s/ Francoise Bouchart

		 	Name: Francoise Bouchart
		 	Title: Vice President

 [Signature Page to Amendment to JPY 2012 Credit Agreement] 

 [Signature pages of Lenders omitted and on file with the registrant] 

[Signature Page to Amendment to JPY 2012 Credit Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}]]